Where care and collaboration meet, to make a difference when it matters most
Mundipharma Pharmaceuticals Limited
United Drug House
Magna Drive
Magna Business Park
Citywest Road
Dublin 24
D24 XKE5
Ireland
Tel: +353 1 2063800
Email: [email protected]
Media enquiries
Global media office Email: [email protected]
Careers
If you’re looking for a role where you can make a difference when it matters most, we want to hear from you. Click here to see the current opportunities to join our team.
Report a side effect:
Patient safety is very important to us.
If you experience any side effects, please speak to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects, you can help provide more information on the safety of medicine.
If you are a patient, or are aware of a patient who has experienced a side effect with one of our products, you can report it here:
Disclosure of payments
To advance patient care, like many other pharmaceutical organisations, we work collaboratively with healthcare professionals and healthcare organisations.
Our policies and procedures provide instructions to employees on the rules and approval processes required for engagements with healthcare professionals, to help ensure that such engagements are only for lawful and legitimate business needs, are appropriately documented, are compensated according to fair market value, and do not interfere with a healthcare professional’s independent medical judgment.
In accordance with this and to ensure transparency of our partnerships, we will publish the full disclosure of all Transfers of Value (TOV) to healthcare professionals and healthcare organisations in accordance with the requirements of Annex V of the IPHA Code of Practice for the Pharmaceutical Industry (The Code). In accordance with the requirements of Annex III of The Code, we will also publish a list of patient organisations to which we provide financial support and/or significant indirect/non-financial support.
Methodology for disclosing Transfers of Value (TOV)
The details of the TOV are gathered from our internal finance and reporting systems. Data is then used to populate the template. This template was developed to ensure clarity of data and ease of understanding. All payments are reported in Euro. Where payments were made in other currencies Mundipharma Pharmaceuticals Limited has used its own internal currency exchange rate to convert the amount to Euro. Details of these exchange rates are available on request. All amounts disclosed are exclusive of VAT. Disclosures for the previous year will be made within 6 months of the following calendar year e.g., all TOVs for the calendar year 2015 will be made public by end June 2016 at the latest. Each annual statement will contain all TOVs which actually occurred during that calendar year.
Where possible, all TOVs will be disclosed on an individual basis. For TOVs, where certain information cannot be disclosed on an individual basis for valid legal reasons, the amount attributable will be disclosed on an aggregate basis. The number of recipients involved will be stated together with the percentage of all recipients that they represent and the aggregate amount attributable to TOVs to such recipients.
This information will remain on a central report hosted by IPHA www.transferofvalue.ie for three years from the time of disclosure.
Mundipharma Integrity Line
We take compliance very seriously and adhere to the laws and regulations of the countries in which we operate. If you think something is not right, please speak up so that we can address your concerns and take appropriate action.
We also encourage you to raise questions or suggestions for improvement regarding our policies and procedures.
Mundipharma prohibits any form of retaliation towards an individual that raises a concern in good faith.
Please use the Mundipharma Integrity Line to raise your questions or concerns.